(Q42499209)

1 November 2017

title

Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects). (English)

1 reference

1 November 2017

Kenneth V Honn

1

1 reference

1 November 2017

Amer Aref

2

1 reference

1 November 2017

Yong Q Chen

3

1 reference

1 November 2017

Michael L Cher

4

1 reference

1 November 2017

John D Crissman

5

1 reference

1 November 2017

Jeffrey D Forman

6

1 reference

1 November 2017

Xiang Gao

7

1 reference

1 November 2017

David Grignon

8

1 reference

1 November 2017

Maha Hussain

9

1 reference

1 November 2017

Arthur T Porter

10

1 reference

1 November 2017

Edson J Pontes

11

1 reference

1 November 2017

Isaac Powell

12

1 reference

1 November 2017

Bruce Redman

13

1 reference

1 November 2017

Wael Sakr

14

1 reference

1 November 2017

Richard Severson

15

1 reference

1 November 2017

Dean G Tang

16

1 reference

1 November 2017

David P Wood

17

1 reference

1 November 2017

publication date

1 January 1996

1 reference

Pathology Oncology Research

1 November 2017

published in

1 reference

1 November 2017

volume

2

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

191-211

1 reference

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Serum metalloproteinases and their inhibitors: markers for malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Induction of the TRPM-2 gene in cells undergoing programmed death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02903527

The biochemistry of programmed cell death

21 January 2018

1 reference

12 December 2020

Activation of a Ca2+-Mg2+-dependent endonuclease as an early event in castration-induced prostatic cell death

1 reference

12 December 2020

1 reference

12 December 2020

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

1 reference

12 December 2020

Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate

1 reference

12 December 2020

12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha

1 reference

12 December 2020

Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients

1 reference

12 December 2020

Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression

1 reference

12 December 2020

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

1 reference

12 December 2020

Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.

1 reference

12 December 2020

Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI).

1 reference

12 December 2020

Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters

1 reference

12 December 2020

Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration

1 reference

12 December 2020

Protease activation during apoptosis: death by a thousand cuts?

1 reference

12 December 2020

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

12 December 2020

Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase

1 reference

12 December 2020

Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma

1 reference

12 December 2020

False positive prostate specific antigen values in the sera of women with renal cell carcinoma

1 reference

12 December 2020

Urinary tissue factor levels in prostatic carcinoma: a potential marker of metastatic spread?

1 reference

12 December 2020

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma

1 reference

12 December 2020

Apoptosis, oncosis, and necrosis. An overview of cell death

1 reference

12 December 2020

Role of prostate-specific antigen as a predictor of outcome in prostate cancer

1 reference

12 December 2020

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

1 reference

12 December 2020

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

1 reference

12 December 2020

Melanoma cell spreading on fibronectin induced by 12(S)‐HETE involves both protein kinase C‐ and protein tyrosine kinase‐dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK)

1 reference

12 December 2020

E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis

1 reference

12 December 2020

Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor.

1 reference

12 December 2020

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

1 reference

12 December 2020

Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue

1 reference

12 December 2020

Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer

1 reference

12 December 2020

Tumor suppressor gene p53 mutations in human prostate cancer

1 reference

12 December 2020

Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors.

1 reference

12 December 2020

Sclerosing Adenosis of the Prostate Histopathologic and Immunohistochemical Analysis

1 reference

12 December 2020

Histologic grading of prostate cancer: a perspective

1 reference

12 December 2020

Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

Androgen repression of the production of a 29-kilodalton protein and its mRNA in the rat ventral prostate

1 reference

12 December 2020

The prostatic capsule: does it exist? Its importance in the staging and treatment of prostatic carcinoma

1 reference

12 December 2020

Serum prostate-specific antigen and the biologic progression of prostate cancer

1 reference

12 December 2020

Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

1 reference

12 December 2020

Mutant p53 expression in prostate carcinoma

1 reference

12 December 2020

Androgen-repressed messages in the rat ventral prostate

1 reference

12 December 2020

Staging of prostate cancer

1 reference

12 December 2020

Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer

1 reference

12 December 2020

Programmed death of nonproliferating androgen-independent prostatic cancer cells.

1 reference

12 December 2020

Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue, in primary prostatic tumors and in their metastases

1 reference

12 December 2020

Apoptotic index as a biomarker in prostatic intraepithelial neoplasia (PIN) and prostate cancer

1 reference

12 December 2020

Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma

1 reference

12 December 2020

Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl‐2 expression

1 reference

12 December 2020

Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C

1 reference

12 December 2020

Role of calcium in the programmed death of rat prostatic glandular cells

1 reference

12 December 2020

Androgen regulation of programmed death of normal and malignant prostatic cells

1 reference

12 December 2020

Mucin in prostatic adenocarcinoma.

1 reference

12 December 2020

Calcium-mediated cell injury and cell death

1 reference

12 December 2020

Neuroendocrine differentiation in human prostatic carcinoma

1 reference

12 December 2020

Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo

1 reference

12 December 2020

Potential effects of age-specific reference ranges for serum prostate-specific antigen

1 reference

12 December 2020

Nucleoli in low-grade prostate adenocarcinoma and adenosis

1 reference

12 December 2020

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

1 reference

12 December 2020

Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells.

1 reference

12 December 2020

Nucleolar prominence as a diagnostic variable in prostatic carcinoma.

1 reference

12 December 2020

Origin and development of carcinoma in the prostate

1 reference

12 December 2020

Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared

1 reference

12 December 2020

Expression of the prostate-specific membrane antigen

1 reference

12 December 2020

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo

1 reference

12 December 2020

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

1 reference

12 December 2020

Benign prostatic hyperplasia: it is a premalignant lesion?

1 reference

12 December 2020

Beta 1 integrin expression on human small cell lung cancer cells

1 reference

12 December 2020

A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenografts

1 reference

12 December 2020

Heterogeneity of prostate cancer in radical prostatectomy specimens

1 reference

12 December 2020

In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells

1 reference

12 December 2020

Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies

1 reference

12 December 2020

Fifteen years' experience of combined hormone/chemotherapy in metastatic prostate cancer

1 reference

12 December 2020

What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker

1 reference

12 December 2020

Mucinous metaplasia in the prostate gland.

1 reference

12 December 2020

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

12 December 2020

Ultrasound guided seminal vesicle biopsies in men with suspected prostate cancer

1 reference

12 December 2020

Immunoreactive prostatic specific antigen in male periurethral glands

1 reference

12 December 2020

The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer

1 reference

12 December 2020

Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy.

1 reference

12 December 2020

The TNM classification of prostate cancer

1 reference

12 December 2020

Human prostate-specific antigen: structural and functional similarity with serine proteases

1 reference

12 December 2020

Recent results of management of palpable clinically localized prostate cancer

1 reference

12 December 2020

Protein phosphorylation in apoptosis.

1 reference

12 December 2020

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate

1 reference

12 December 2020

The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin

1 reference

12 December 2020

Human prostatic acid phosphatase: selected properties and practical applications

1 reference

12 December 2020

Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs.

1 reference

12 December 2020

Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma.

1 reference

12 December 2020

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

1 reference

12 December 2020

Staging of early prostate cancer: a proposed tumor volume-based prognostic index

1 reference

12 December 2020

"Thymineless" death in androgen-independent prostatic cancer cells

1 reference

12 December 2020

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

1 reference

12 December 2020

Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents

1 reference

12 December 2020

Prostate-specific antigen in milk of lactating women

1 reference

12 December 2020

Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix

1 reference

12 December 2020

College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Prostate Cancer Working Group.

1 reference

12 December 2020

Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast

1 reference

12 December 2020

Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction

1 reference

12 December 2020

Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion

1 reference

12 December 2020

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

12 December 2020

Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function

1 reference

12 December 2020

bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis

1 reference

12 December 2020

False-positive serum prostate-specific antigen values in a patient with non-Hodgkin lymphoma of the kidney

1 reference

12 December 2020

12-Lipoxygenase, 12(S)-HETE, and cancer metastasis

1 reference

12 December 2020

Clusterin Insights into a multifunctional protein

1 reference

12 December 2020

Decreased expression of E-cadherin in the progression of rat prostatic cancer

1 reference

12 December 2020

Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations

1 reference

12 December 2020

Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer

1 reference

12 December 2020

OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate

1 reference

12 December 2020

Retinoids and apoptosis: implications for cancer chemoprevention and therapy

1 reference

12 December 2020

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).

1 reference

12 December 2020

Apoptosis and the cell cycle

1 reference

12 December 2020

Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation

1 reference

12 December 2020

Metastatic phenotype: growth factor dependence and integrin expression

1 reference

12 December 2020

Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells

1 reference

12 December 2020

Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique

1 reference

12 December 2020

Biomarkers associated with prostate cancer progression

1 reference

12 December 2020

Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3.

1 reference

12 December 2020

p53 in prostate cancer: frequent expressed transition mutations

1 reference

12 December 2020

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

1 reference

12 December 2020

Influence of Preoperative Positive Seminal Vesicle Biopsy on the Staging of Prostatic Cancer

1 reference

12 December 2020

E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas

1 reference

12 December 2020

The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens

1 reference

12 December 2020

12-lipoxygenases and 12(S)-HETE: role in cancer metastasis

1 reference

12 December 2020

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

12 December 2020

Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade in predicting pelvic lymph node metastases

1 reference

12 December 2020

Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53.

1 reference

12 December 2020

Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities

1 reference

12 December 2020

Screening for prostatic carcinoma with prostate specific antigen

1 reference

12 December 2020

Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study

1 reference

12 December 2020

Platelets and cancer metastasis: more than an epiphenomenon

1 reference

12 December 2020

Cellular regulation of tissue factor

1 reference

12 December 2020

Biological diversity in metastatic neoplasms: origins and implications.

1 reference

12 December 2020

1 reference

12 December 2020

The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model

1 reference

12 December 2020

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

12 December 2020

Tumor marker doubling time in patients with prostate cancer: determination of prostate-specific antigen and prostatic acid phosphatase doubling time

1 reference

12 December 2020

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

12 December 2020

Probing the molecular program of apoptosis by cancer chemopreventive agents.

1 reference

12 December 2020

12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis

1 reference

12 December 2020

Induction of apoptosis by beta-lapachone in human prostate cancer cells

1 reference

12 December 2020

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer

1 reference

12 December 2020

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

12 December 2020

The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens

1 reference

12 December 2020

Density-dependent induction of apoptosis by transforming growth factor-beta 1 in a human ovarian carcinoma cell line

1 reference

12 December 2020

Fatty acid synthesis: a potential selective target for antineoplastic therapy

1 reference

12 December 2020

Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate

1 reference

12 December 2020

Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator

1 reference

12 December 2020

Both transforming growth factor-beta and substrate release are inducers of apoptosis in a human colon adenoma cell line

1 reference

12 December 2020

Neuroimmunodegeneration: do neurons and T cells use common pathways for cell death?

1 reference

12 December 2020

Microsatellite instability in prostate cancer.

1 reference

12 December 2020

p53 is mutated in a subset of advanced-stage prostate cancers

1 reference

12 December 2020

Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread

1 reference

12 December 2020

Sclerosing adenosis of the prostate gland. A lesion showing myoepithelial differentiation

1 reference

12 December 2020

Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta

1 reference

12 December 2020

Atrophy and proliferation in the young adult prostate.

1 reference

12 December 2020

Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland

1 reference

12 December 2020

Prostate specific antigen and prostatic acid phosphatase immunoreactivity as prognostic indicators of advanced prostatic carcinoma

1 reference

12 December 2020

Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer

1 reference

12 December 2020

Detection of hematogenous micrometastasis in patients with prostate cancer

1 reference

12 December 2020

Assay for prostate specific antigen (PSA): problems and possible solutions

1 reference

12 December 2020

Immunohistochemistry of prostatic acid phosphatase

1 reference

12 December 2020

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer

1 reference

12 December 2020

Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression

1 reference

12 December 2020

Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease

1 reference

12 December 2020

Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides

1 reference

12 December 2020

Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen

1 reference

12 December 2020

Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line

1 reference

12 December 2020

Adhesion molecules and tumor metastasis: an update.

1 reference

12 December 2020

Effect of transforming growth factor-beta 1 on proliferation and death of rat prostatic cells

1 reference

12 December 2020

Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells

1 reference

12 December 2020

Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma

1 reference

12 December 2020

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

12 December 2020

Regulation of lymphocyte survival by the bcl-2 gene family

1 reference

12 December 2020

v-rasH expression confers hormone-independent in vitro growth to LNCaP prostate carcinoma cells

1 reference

12 December 2020

Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death.

1 reference

12 December 2020

Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma

1 reference

12 December 2020

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

1 reference

12 December 2020

Prostatic cell lineage markers: emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration

1 reference

12 December 2020

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen

1 reference

12 December 2020

Intraluminal crystalloids in whole-organ sections of prostate

1 reference

12 December 2020

Integrin expression in human melanoma cells with differing invasive and metastatic properties

1 reference

12 December 2020

The Value of Serum Enzymatic Acid Phosphatase in the Staging of Localized Prostate Cancer

1 reference

12 December 2020

Human prostatic acid phosphatase: cDNA cloning, gene mapping and protein sequence homology with lysosomal acid phosphatase

1 reference

12 December 2020

Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression

1 reference

12 December 2020

Small-acinar patterns in the prostate gland with emphasis on atypical adenomatous hyperplasia and small-acinar carcinoma.

1 reference

12 December 2020

Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin

1 reference

12 December 2020

Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death

1 reference

12 December 2020

Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response

1 reference

12 December 2020

Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin).

1 reference

12 December 2020

Adenosis of the prostate. Histologic features in needle biopsy specimens.

1 reference

12 December 2020

p53 gene alterations in human prostate carcinoma

1 reference

12 December 2020

Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland

1 reference

12 December 2020

Morphogenesis of prostatic carcinoma

1 reference

12 December 2020

Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors

1 reference

12 December 2020

Expression of the prostate-specific antigen gene by a primary ovarian carcinoma

1 reference

12 December 2020

Adhesion molecules and tumor cell-vasculature interactions: modulation by bioactive lipid molecules

1 reference

12 December 2020

Anatomy of the prostate: an historical survey of divergent views

1 reference

12 December 2020

Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens

1 reference

12 December 2020

N-acetylcysteine (NAC) and glutathione (GSH): antioxidant and chemopreventive properties, with special reference to lung cancer.

1 reference

12 December 2020

Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin.

1 reference

12 December 2020

A report of the workshops on the current status of the histologic grading of prostate cancer

1 reference

12 December 2020

Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.

1 reference

12 December 2020

Diagnostic markers of prostate cancer: utility of prostate-specific antigen in diagnosis and staging

1 reference

12 December 2020

Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide

1 reference

12 December 2020

Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications

1 reference

12 December 2020

Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate

1 reference

12 December 2020

Castration-induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice

1 reference

12 December 2020

Current and proposed biologic markers in prostate cancer: 1994.

1 reference

12 December 2020

Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases.

1 reference

12 December 2020

High frequency of mutator phenotype in human prostatic adenocarcinoma

1 reference

12 December 2020

A pilot trial of chemohormonal therapy for metastatic prostate carcinoma

1 reference

12 December 2020

Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers

1 reference

12 December 2020

Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients

1 reference

12 December 2020

Prostatic carcinoma: problems in the interpretation of prostatic biopsies

1 reference

12 December 2020

Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells

1 reference

12 December 2020

Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors

1 reference

12 December 2020

Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma

1 reference

12 December 2020

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

1 reference

12 December 2020

Evaluation of biomarkers in breast and prostate cancer

1 reference

12 December 2020

Implication of cell kinetic changes during the progression of human prostatic cancer

1 reference

12 December 2020

Prostate-specific antigen: biochemistry, analytical methods, and clinical application

1 reference

12 December 2020

Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy X 6 versus 10 Gy X 2.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02903527

1 reference

1 November 2017

1 reference